(Q44430269)

2 December 2017

title

A panel of five circulating microRNAs as potential biomarkers for prostate cancer (English)

1 reference

2 December 2017

0 references

1 reference

1 reference

Zhang-Hui Chen

1

1 reference

2 December 2017

Guang-Lin Zhang

2

1 reference

2 December 2017

Huan-Rong Li

3

1 reference

2 December 2017

Jin-Dan Luo

4

1 reference

2 December 2017

Zhong-Xiang Li

5

1 reference

2 December 2017

Ge-Ming Chen

6

1 reference

2 December 2017

Jun Yang

7

1 reference

2 December 2017

publication date

1 February 2012

1 reference

2 December 2017

1 reference

2 December 2017

volume

72

1 reference

2 December 2017

issue

13

1 reference

2 December 2017

page(s)

1443-1452

1 reference

2 December 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Management of advanced prostate cancer after first-line chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Early chemotherapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Critical review of complementary therapies for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Use of percentage of free prostate-specific antigen to identify men at high risk of prostate cancer when PSA levels are 2.51 to 4 ng/mL and digital rectal examination is not suspicious for prostate cancer: an alternative model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Insignificant prostate cancer and active surveillance: from definition to clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Urine biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Emerging biomarkers for the diagnosis and prognosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

How do microRNAs regulate gene expression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Gene silencing by microRNAs: contributions of translational repression and mRNA decay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

MicroRNAs and cancer: current state and future perspectives in urologic oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Differences in prognostic factors and survival among white and Asian men with prostate cancer, California, 1995-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Selecting subsets of newly extracted features from PCA and PLS in microarray data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Interpretation of ANOVA models for microarray data using PCA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

MicroRNA expression profiling in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Circulating microRNAs, potential biomarkers for drug-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Cancerous miRNAs and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3' untranslated region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

Active surveillance for prostate cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.22495

21 January 2018

Identifiers

DOI

10.1002/PROS.22495

1 reference

2 December 2017

1 reference